Stranded Technologies Podcast
by Infinita
Latest episode
Ep. 119: Jessica Flanigan on Why Patients Should Be Able to Choose…
Ep. 119: Jessica Flanigan on Why Patients Should Be Able to Choose…
About this podcast
Infinita is building early clinical access pathways for biotech acceleration such as Prospera and Montana SB535. This is the Infinita community's main channel for news, podcast episodes, event announcements & more.
www.infinitatimes.com
Episodes
The newest 20 of 122 episodes
- Ep. 119: Jessica Flanigan on Why Patients Should Be Able to Choose Their Own Medicine · 59 minJessica Flanigan is a philosopher at the University of Richmond, where she holds the Richard L. Morrill Chair in Ethics and Democratic Values. She is the author of Pharmaceutical…
- Ep. 118: Holly Fernandez on the Ethics and Practice of Pre-Approval Drug Access through Expanded Access vs. Right-to-Try · 1 h 19 minHolly Fernandez Lynch is is Associate Professor of Medical Ethics and Law at the University of Pennsylvania, and one of the most influential voices in US bioethics on questions…
- Ep. 117: John Cochrane on Rethinking Healthcare, Markets, Regulation & the FDA · 1 h 2 minJohn Cochrane, economist and professor of finance at Stanford Graduate School of Business and fellow at the Hoover Institution, joins the podcast to discuss the first principles…
- Ep. 116: Anthony DiGiorgio & Anish Koka on the Rules That Undermine Independent Medicine and Misaligned Healthcare Incentives from Practitioners’ Perspectives · 1 h 5 minNiklas sits down with Dr. Anish Koka, a practicing cardiologist, and Dr. Anthony DiGiorgio, a neurosurgeon and academic, co-hosts of The Doctor’s Lounge. It’s a dense…
- Ep. 115: Crémieux & Soham Sankaran -The Case for Vaccine Acceleration (vacc/acc) · 1 h 3 minSoham is the founder of PopVax, a company building vaccines faster and cheaper using AI, mRNA platforms, and a radically efficient preclinical pipeline based in India. Crémieux…
- Ep. 114: The Ultimate Guide to Montana SB535: A US State’s Path to Accelerate Biotech & Patient Access · 1 h 26 minIn this episode, Niklas Anzinger sits down with Stephen Martin, U.S. Lead at Infinita and Operations Lead of the Montana Experimental Treatment Review Board (ETRB), to explore…
- Ep. 113. Reason on Clinical Trials, Medical Tourism, and the Data the FDA Won’t See · 54 minReason, co-founder and CEO of Repair Biotechnologies and a longevity industry veteran with a background in astrophysics, joins us to talk about what it actually takes to test a…
- Ep. 112: Tim Urban on Startup Cities, AI Safety, Longevity, and Building Better Societies · 58 minTim Urban, creator of Wait But Why and the mind behind one of the most-watched TED Talks of all time, joins us to talk about why progress does not happen automatically. In this…
- Ep. 111: Antonio García Martínez on Crypto, Network States, and Building New Cities · 49 minAntonio Garcia Martinez is a writer, entrepreneur, and director at Base, Coinbase’s Ethereum L2. Before that he sold a startup to Twitter, worked on ads at Facebook, and wrote…
- Ep. 110: Tomas Pueyo & Trey Goff On The Next Silicon Valley Might Be A New Country · 2 h 27 minIn this episode, the famous blogger Tomas Pueyo (Uncharted Territories) interviews Trey Goff (Chief of Staff & Head of Public Policy at Prospera) & Niklas Anzinger (Founder & CEO…
- Ep. 109: Jonathan Anomaly on The Future of Human Enhancement, Genetic Selection & Startup Societies · 1 h 21 minIn this episode, Jonathan Anomaly joins us to discuss the collapse of trust in modern institutions, the rise of tribal politics, and why liberty increasingly depends on exit…
- Ep. 108: The Buck Inst. President, Eric Verdin, on Pathways to Life Extension Acceleration: Alternative Pathways and Radical Hopium vs. Scientific Realism · 46 minIn this episode, we sit down with Eric Verdin, CEO of the Buck Institute, one of the world’s leading institutes dedicated to aging and longevity research.Eric has often been…
- Ep. 107: Sid Sijbrandij On Beating Cancer with First Principles, n = 1 Personalized Treatments and Special Access Regulatory Pathways · 47 minSid Sijbrandij is the co-founder of GitLab, one of the world’s largest open-source software companies. But in 2022, his life took a radical turn — he was diagnosed with a rare…
- Ep. 106: Yaron Brook: Capitalism, Ayn Rand, and the Moral Case for Freedom · 1 h 12 min · Season 1 Episode 106Yaron Brook, chairman of the Ayn Rand Institute and host of the Yaron Brook Show, joins Niklas to discuss the moral and philosophical foundations of capitalism. They explore Ayn…
- Ep. 105: Andrew Hessel: Programming DNA and Engineering the Future of Life · 1 h 5 min · Season 1 Episode 105In this episode, he and Niklas explore how genome sequencing, DNA synthesis, and CRISPR are turning life into an engineering platform. From coding proteins and viruses to writing…
- Ep. 104: Ruxandra Teslo: Clinical Trials, Drug Innovation, and the Bottleneck to Biotech Abundance · 1 h 2 min · Season 1 Episode 104In this episode, she and Niklas explore why drug development takes over a decade, why only ~10% of drugs reach approval, and how clinical trials have become one of the biggest…
- Ep. 103: Ian Huyett on Right to Try, Christian Techno Optimism, and Biotech Federalism · 1 h 3 minIan Huyett is an attorney at Cornerstone in New Hampshire, where he leads litigation and policy work for a network of over one hundred churches. He helped design New Hampshire’s…
- Ep. 102: Arjun Khemani: Zcash, Radical Privacy, and the New Renaissance · 58 minArjun Khemani is one of the sharpest young thinkers in the progress movement.He dropped out of high school at 16, built apps with Naval’s team, ran a podcast with guests like…
- Ep. 101: Bryan Caplan: Pro Market & Pro Business, the Real Ethics of Entrepreneurship · 1 h 5 minEp. 101: Bryan Caplan: Pro Market & Pro Business, the Real Ethics of Entrepreneurship Bryan Caplan is a professor of economics at George Mason University and the author of…
- Ep. 100: A Conversation with Dr. Mary Ruwart: The Lost Innovation Cost of the FDA, and How Founders Can Reclaim the Right to Build · 1 h 17 minNiklas sits down with biomedical researcher and libertarian author Mary Ruwart (Death by Regulation) to dissect how decades of FDA rules derailed innovation, extended timelines…
